Meanwhile, previous studies suggested that XIST overexpression was highly correlated with poor prognosis of patients with various cancers, such as breast cancer [9], pancreatic cancer (PC) [10] and brain cancer [11]. This evidence concerns the gene XIST and breast carcinoma.